EHAB
Enhabit, Inc. NYSE Listed Jun 23, 2022$13.80
+0.07%
vs $13.79
Mkt Cap $701.0M
52w Low $6.52
96.2% of range
52w High $14.09
50d MA $13.76
200d MA $10.26
P/E (TTM)
-152.3x
EV/EBITDA
12.5x
P/B
1.2x
Debt/Equity
0.9x
ROE
-0.9%
P/FCF
10.7x
RSI (14)
75.00
ATR (14)
$0.02
Beta
1.08
50d MA
$13.76
200d MA
$10.26
Avg Volume
1.0M
Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company also offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. As of March 31, 2022, it operated in 252 home health agencies and 99 hospice agencies across 34 states. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was incorporated in 2014 and is headquartered in Dallas, Texas. As of July 1, 2022, Enhabit, Inc. operates as a standalone company.
6688 N. Central Expressway · Dallas, TX 75206 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | AMC | 0.14 | 0.14 | +0.0% | 13.61 | -0.1% | +0.0% | +0.0% | +0.4% | -0.4% | +0.1% | — |
| Nov 5, 2025 | AMC | 0.12 | 0.17 | +41.7% | 8.21 | +2.9% | -6.1% | +3.1% | -0.3% | +0.8% | +0.8% | — |
| Aug 6, 2025 | AMC | 0.10 | 0.13 | +30.0% | 6.77 | +4.1% | +15.2% | -2.3% | -4.5% | +3.6% | +0.4% | — |
| May 7, 2025 | AMC | 0.07 | 0.10 | +42.9% | 8.20 | +5.6% | +18.2% | +6.1% | +1.8% | +0.1% | +1.1% | — |
| Mar 5, 2025 | AMC | 0.07 | 0.04 | -42.9% | 8.54 | -8.8% | -6.1% | +6.4% | +1.6% | -2.5% | +1.1% | — |
| Nov 6, 2024 | AMC | 0.04 | 0.03 | -21.1% | 7.91 | -2.5% | +0.1% | -0.4% | +1.5% | -5.0% | +0.0% | — |
| Aug 6, 2024 | AMC | 0.06 | 0.07 | +16.7% | 9.89 | -5.2% | -14.1% | +0.2% | -0.7% | -3.4% | +7.8% | — |
| May 8, 2024 | AMC | 0.05 | 0.07 | +40.0% | 9.70 | -22.1% | -14.5% | +0.6% | +3.6% | +4.6% | -4.2% | — |
| Mar 6, 2024 | AMC | 0.03 | 0.06 | +128.0% | 7.86 | +20.0% | +22.1% | +7.7% | -4.4% | +5.4% | +4.0% | — |
| Nov 7, 2023 | AMC | 0.06 | 0.03 | -48.3% | 8.55 | +0.2% | +16.0% | -4.9% | -1.4% | -1.1% | +6.1% | — |
| Aug 9, 2023 | AMC | 0.14 | 0.04 | -71.4% | 13.70 | -6.3% | -13.8% | -2.6% | +4.1% | -5.4% | +1.3% | — |
| May 9, 2023 | AMC | 0.12 | 0.09 | -25.0% | 13.51 | +0.3% | -8.7% | +3.8% | -4.5% | -0.8% | -2.0% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 6 | TD Cowen | Downgrade | Buy → Hold | — | $13.61 | $13.60 | -0.1% | +0.0% | +0.4% | -0.4% | +0.1% | -0.1% |
| Feb 24 | UBS | Downgrade | Buy → Neutral | — | $13.60 | $13.59 | -0.1% | -0.3% | +0.1% | +0.1% | +0.1% | -0.2% |
| Feb 23 | Jefferies | Downgrade | Buy → Hold | — | $11.09 | $13.58 | +22.5% | +22.6% | -0.3% | +0.1% | +0.1% | +0.1% |
| Feb 23 | Leerink Partners | Maintains | Market Perform → Market Perform | — | $11.09 | $13.58 | +22.5% | +22.6% | -0.3% | +0.1% | +0.1% | +0.1% |
| Jan 22 | Oppenheimer | Upgrade | Perform → Outperform | — | $10.74 | $11.10 | +3.4% | +3.1% | -2.5% | -0.6% | -3.3% | -0.6% |
| Jan 13 | TD Cowen | Upgrade | Hold → Buy | — | $10.19 | $11.11 | +9.0% | +7.5% | -1.4% | +0.8% | -3.4% | -0.9% |
| Jan 8 | UBS | Upgrade | Neutral → Buy | — | $9.51 | $10.04 | +5.6% | +7.2% | -2.2% | +2.2% | +7.5% | -1.4% |
| Aug 8 | UBS | Maintains | Neutral → Neutral | — | $7.80 | $7.72 | -1.0% | -2.3% | -4.5% | +3.6% | +0.4% | -2.4% |
| Dec 9 | Jefferies | Upgrade | Hold → Buy | — | $7.73 | $8.17 | +5.7% | +13.2% | -1.8% | -0.7% | -0.1% | +0.0% |
| Nov 19 | Leerink Partners | Maintains | Market Perform → Market Perform | — | $7.14 | $7.05 | -1.3% | +1.8% | +2.6% | +0.1% | +1.2% | +0.8% |
| Jun 27 | BofA Securities | Maintains | Underperform → Underperform | — | $8.49 | $8.39 | -1.2% | +0.9% | +4.1% | -1.9% | +0.1% | +0.0% |
| May 14 | Leerink Partners | Upgrade | Underperform → Market Perform | — | $8.64 | $8.91 | +3.1% | +4.6% | -4.2% | -3.6% | -1.2% | +8.5% |
| May 9 | Jefferies | Downgrade | Buy → Hold | — | $9.70 | $7.56 | -22.1% | -14.5% | +0.6% | +3.6% | +4.6% | -4.2% |
| Mar 11 | TD Cowen | Maintains | Market Perform → Market Perform | — | $10.34 | $10.14 | -1.9% | -4.4% | +5.4% | +4.0% | +0.1% | +1.5% |
| Mar 7 | UBS | Upgrade | Sell → Neutral | — | $7.86 | $9.43 | +20.0% | +22.1% | +7.7% | -4.4% | +5.4% | +4.0% |
| Mar 7 | Oppenheimer | Maintains | Perform → Perform | — | $7.86 | $9.43 | +20.0% | +22.1% | +7.7% | -4.4% | +5.4% | +4.0% |
| Mar 6 | Jefferies | Maintains | Buy → Buy | — | $7.92 | $7.91 | -0.1% | -0.8% | +22.1% | +7.7% | -4.4% | +5.4% |
| Aug 11 | Credit Suisse | Maintains | Neutral → Neutral | — | $11.81 | $11.51 | -2.5% | -2.6% | +4.1% | -5.4% | +1.3% | +1.4% |
| Jul 17 | Goldman Sachs | Maintains | Neutral → Neutral | — | $12.63 | $12.19 | -3.5% | +0.1% | +0.6% | +6.2% | +1.4% | +4.9% |
| Mar 16 | Goldman Sachs | Maintains | Neutral → Neutral | — | $14.25 | $14.06 | -1.3% | -0.8% | -4.3% | -1.6% | +2.9% | +0.3% |
| Feb 17 | Citigroup | Maintains | Neutral → Neutral | — | $15.74 | $15.73 | -0.1% | -0.6% | +0.0% | +0.4% | +0.4% | -2.5% |
| Feb 16 | Credit Suisse | Maintains | Neutral → Neutral | — | $15.99 | $15.67 | -2.0% | -1.6% | -0.6% | +0.0% | +0.4% | +0.4% |
| Dec 13 | CJS Securities | Maintains | Market Perform → Perform | — | $13.97 | $13.87 | -0.7% | -0.4% | +0.7% | -0.1% | -3.9% | -1.2% |
| Dec 8 | UBS | Maintains | Sell → Sell | — | $14.59 | $14.02 | -3.9% | -6.2% | +1.2% | +0.9% | -0.4% | +0.7% |
| Dec 6 | Stifel | Maintains | Buy → Buy | — | $13.68 | $14.05 | +2.7% | +6.7% | -0.1% | -6.2% | +1.2% | +0.9% |
| Nov 4 | Credit Suisse | Maintains | Neutral → Neutral | — | $12.60 | $12.54 | -0.5% | +0.4% | +3.2% | -0.4% | -1.8% | +0.1% |
| Oct 14 | Oppenheimer | Maintains | Perform → Perform | — | $12.76 | $12.69 | -0.5% | -2.6% | +3.1% | +4.4% | -1.8% | -2.3% |
| Aug 30 | Jefferies | Maintains | Buy → Buy | — | $15.04 | $15.43 | +2.6% | +6.2% | +3.9% | -7.1% | -0.1% | +7.7% |
| Aug 25 | Credit Suisse | Maintains | Neutral → Neutral | — | $15.85 | $15.50 | -2.2% | -3.3% | -2.1% | +0.3% | +6.2% | +3.9% |
| Aug 18 | Citigroup | Maintains | Neutral → Neutral | — | $14.30 | $13.98 | -2.2% | -1.6% | +3.5% | +5.8% | +2.1% | +0.7% |
| Jul 13 | BofA Securities | Maintains | Underperform → Underperform | — | $18.80 | $17.98 | -4.4% | -4.3% | -3.9% | +7.2% | +0.1% | -0.9% |
No insider trades available.
8-K
Enhabit, Inc. -- 8-K Filing
May 15
8-K · 8.01
!! High
Enhabit, Inc. -- 8-K 8.01: Material Event / Announcement
May 12
8-K
Enhabit, Inc. -- 8-K Filing
Enhabit faces shareholder litigation alleging its proxy statement contained material misrepresentations regarding management financial projections and Goldman Sachs' valuation analyses, creating potential legal and financial exposure.
May 5
8-K
Unknown — 8-K Filing
The merger is progressing on schedule with regulatory approval secured, suggesting the deal will close in Q2 2026 as planned, reducing execution risk for shareholders awaiting the transaction completion.
Apr 16
8-K · 7.01
! Medium
Enhabit, Inc. -- 8-K 7.01: Regulation FD Disclosure
Enhabit disclosed material non-public information to select parties, potentially creating information asymmetry and raising concerns about fair market access to critical company updates for all shareholders.
Mar 5
8-K · 1.01
! Medium
Enhabit, Inc. -- 8-K 1.01: Financing / Debt Agreement
Enhabit secured a five-year credit facility with SOFR-based variable interest rates, providing flexible financing for operations while exposing the company to interest rate fluctuations.
Mar 4
8-K · 5.02
!!! Very High
Enhabit, Inc. -- 8-K 5.02: Executive Change
Enhabit appointed Ryan Solomon as Chief Financial Officer, replacing Collin McQuiddy who resigned as Senior Vice President, signaling potential leadership transition that could impact financial strategy execution.
Feb 27
8-K
Enhabit, Inc. -- 8-K Filing
Enhabit's merger agreement cancels out-of-the-money employee stock options while preserving in-the-money options and RSUs, diluting existing shareholders through the equity consideration structure of the transaction.
Feb 23
8-K · 7.01
! Medium
Enhabit, Inc. -- 8-K 7.01: Regulation FD Disclosure
Enhabit disclosed material information to select parties under Regulation FD, signaling potential market-moving news that all investors should now have access to through this filing.
Feb 12
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Deerfield Management Company, L.p. | 4,747,746 | $67M | — | Mar 2026 |
| 2 | Vanguard Capital Management Llc | 2,137,944 | $30M | New | Mar 2026 |
| 3 | Ubs Group Ag | 2,108,496 | $30M | Added | Mar 2026 |
| 4 | Jana Partners Management | 2,090,412 | $29M | New | Mar 2026 |
| 5 | Arex Capital Management, Lp | 2,493,872 | $23M | — | Dec 2025 |
| 6 | Qube Research & Technologies Ltd | 1,474,716 | $21M | Added | Mar 2026 |
| 7 | D.e. Shaw & Co | 1,210,064 | $17M | Added | Mar 2026 |
| 8 | Soros Fund Management Llc | 1,118,674 | $16M | New | Mar 2026 |
| 9 | Morgan Stanley | 1,415,930 | $13M | Reduced | Dec 2025 |
| 10 | Renaissance Technologies Llc | 787,768 | $11M | Added | Mar 2026 |
| 11 | Glazer Capital, Llc | 678,638 | $10M | New | Mar 2026 |
| 12 | Capula Management Ltd | 645,000 | $9M | New | Mar 2026 |
| 13 | Aqr Capital Management Llc | 460,982 | $6M | Added | Mar 2026 |
| 14 | Northern Trust Corp | 421,246 | $6M | Added | Mar 2026 |
| 15 | Vanguard Portfolio Management Llc | 416,098 | $6M | New | Mar 2026 |
| 16 | West Tower Group, Llc | 361,009 | $5M | Reduced | Mar 2026 |
| 17 | Millennium Management | 340,774 | $5M | New | Mar 2026 |
| 18 | Systematic Financial Management Lp | 336,694 | $5M | Reduced | Mar 2026 |
| 19 | Hrt Financial Lp | 317,594 | $4M | Added | Mar 2026 |
| 20 | Sand Grove Capital Management Llp | 289,157 | $4M | New | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$701.0M
Enterprise Value
$1.08B
P/E (TTM)
-152.32x
Forward P/E
22.87x
PEG Ratio
1.05x
P/B
1.24x
P/S
0.66x
P/FCF
10.65x
EV/EBITDA
12.53x
Shares Out
50.8M
Financials (TTM)
Revenue
$1.06B
Net Income
-$4.6M
EBITDA
$86.3M
Free Cash Flow
$65.8M
Op Cash Flow
$70.7M
EPS Basic
$-0.09
EPS Diluted
$-0.09
EPS Forward
$0.60
Gross Margin
46.9%
Op Margin
6.0%
Net Margin
-0.4%
Balance Sheet
Total Assets
$1.17B
Total Liab.
$603.0M
Total Equity
$564.1M
Cash
$43.6M
LT Debt
$423.7M
Book Value/Sh
$11.10
Debt/Equity
0.94x
Current Ratio
1.63
Quick Ratio
1.63
Returns & Growth
ROE
-0.9%
ROA
-0.4%
ROIC
-11.0%
Rev Growth YoY
+2.4%
EPS Growth YoY
+97.1%
Price Returns
2W
—
1M
+0.4%
3M
+1.4%
6M
+54.4%
12M
+31.4%
Technicals
52W High
$14.09
52W Low
$6.52
50d MA
$13.76
200d MA
$10.26
RSI (14)
75.00
ATR (14)
$0.02
Beta
1.08
Avg Volume
1.0M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$13.53
High
$14.00
Low
$12.00
Median
$13.80
Data updated apr 25, 2026 6:41am
· Source: financialmodelingprep.com